UN health agency updates guidelines on COVID-19 therapeutics
The updated “living guidelines” on related therapeutics now include conditional recommendations on the medication, molnupiravir, the UN agency announced on Thursday. Citing concerns and data gaps, WHO advanced that molnupiravir should be provided “only to non-severe COVID-19 patients with the highest risk of hospitalization,” WHO alerted. Those are typically people who have not received a COVID-19 vaccination, older people, people with immunodeficiencies and those…
Read More
